Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Novartis Forschungsstiftung, commonly known as the Novartis Foundation, is a prominent entity in the pharmaceutical and healthcare industry, headquartered in Switzerland (CH). Established in 1996, the foundation focuses on advancing global health through innovative research and development initiatives.
With a strong emphasis on areas such as infectious diseases, cardiovascular health, and access to medicines, the foundation has made significant strides in improving healthcare outcomes worldwide. Its unique approach combines scientific expertise with a commitment to social impact, positioning it as a leader in public health initiatives.
Notable achievements include collaborations with various global health organisations, enhancing its reputation as a key player in addressing pressing health challenges. Through its dedicated efforts, Novartis Forschungsstiftung continues to contribute to the advancement of medical science and the betterment of global health.
+70 vs industry average
Novartis Forschungsstiftung’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Research Services has below-average carbon intensity
The Research Services industry has reduced its overall emissions by 19% since 2018
No reported emissions data is available for Novartis Forschungsstiftung yet.
Novartis Forschungsstiftung, headquartered in Switzerland (CH), currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. However, the foundation is part of a corporate family that includes Novartis AG, which provides a framework for its climate commitments and initiatives.
As a current subsidiary of Novartis AG, Novartis Forschungsstiftung inherits its climate strategies and targets from its parent company. Novartis AG has made significant commitments to reduce its carbon footprint, including participation in various initiatives such as the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which are cascaded down to Novartis Forschungsstiftung.
While specific reduction targets for Novartis Forschungsstiftung are not detailed, the overarching goals set by Novartis AG reflect a strong commitment to sustainability and climate action. The foundation aligns with these initiatives, aiming to contribute to the reduction of greenhouse gas emissions across its operations.
In summary, while Novartis Forschungsstiftung does not currently report specific emissions data, it is committed to the climate goals established by Novartis AG, which include ambitious targets for reducing carbon emissions and enhancing sustainability practices.
Access structured emission data, company specific factors and auditable source documents
No climate goals have been disclosed for Novartis Forschungsstiftung yet.
No scope 3 category breakdown has been disclosed yet.


You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more